Loss Per Share - Schedule of Basic and Diluted Loss Per Share (Details) |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Dec. 31, 2025
CNY (¥)
¥ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
CNY (¥)
¥ / shares
shares
|
Dec. 31, 2023
CNY (¥)
¥ / shares
shares
|
|||
| Numerator: | ||||||
| Net loss | ¥ (130,931,921) | $ (18,723,015) | ¥ (37,365,434) | ¥ (36,949,421) | ||
| Accretion to redemption value of mezzanine equity | (81,648,716) | (11,675,611) | (105,969,614) | (108,440,354) | ||
| Less: Net income attributable to noncontrolling interests | (1,520) | (217) | 25,878 | 1,057 | ||
| Net loss attributable to the Pomdoctor Limited’s ordinary shareholders | ¥ (212,579,117) | $ (30,398,409) | ¥ (143,360,926) | ¥ (145,390,832) | ||
| Denominator: | ||||||
| Weighted average number of shares outstanding – basic (in Shares) | [1] | 9,680,622 | 9,680,622 | 6,310,198 | 6,310,198 | |
| Weighted average number of shares outstanding – diluted (in Shares) | [1] | 9,680,622 | 9,680,622 | 6,310,198 | 6,310,198 | |
| Loss per share – Basic: (in Dollars per share and Yuan Renminbi per share) | (per share) | ¥ (21.96) | $ (3.14) | ¥ (22.72) | ¥ (23.04) | ||
| Loss per share – Diluted: (in Dollars per share and Yuan Renminbi per share) | (per share) | ¥ (21.96) | $ (3.14) | ¥ (22.72) | ¥ (23.04) | ||
| ||||||
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|